Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Drosophila melanogaster
Entry Details
ID
8800
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
O97394 (Created: 2006-03-07 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name
SDK_DROME
Protein Name
Protein sidekick
Gene
sdk
Organism Scientific
Drosophila melanogaster
Organism Common
Fruit fly
Lineage
Eukaryota
Metazoa
Arthropoda
Hexapoda
Insecta
Pterygota
Neoptera
Endopterygota
Diptera
Brachycera
Muscomorpha
Ephydroidea
Drosophilidae
Drosophila
Sophophora
Protein Length [aa]
2224
Protein Mass [Da]
246254
Features
Type
Description
Status
Start
End
signal peptide
potential
1
47
chain
Protein sidekick
48
2224
disulfide bond
by similarity
95
138
disulfide bond
by similarity
283
336
disulfide bond
by similarity
382
433
disulfide bond
by similarity
476
525
disulfide bond
by similarity
567
620
transmembrane region
potential
2002
2022
topological domain
Extracellular
potential
48
2001
topological domain
Cytoplasmic
potential
2023
2224
domain
Ig-like C2-type 1
72
155
domain
Ig-like C2-type 2
261
355
domain
Ig-like C2-type 3
359
445
domain
Ig-like C2-type 4
455
541
domain
Ig-like C2-type 5
546
636
domain
Fibronectin type-III 1
641
748
domain
Fibronectin type-III 2
755
852
domain
Fibronectin type-III 3
857
964
domain
Fibronectin type-III 4
969
1060
domain
Fibronectin type-III 5
1067
1159
domain
Fibronectin type-III 6
1166
1267
domain
Fibronectin type-III 7
1272
1367
domain
Fibronectin type-III 8
1374
1465
domain
Fibronectin type-III 9
1472
1567
domain
Fibronectin type-III 10
1572
1672
domain
Fibronectin type-III 11
1679
1782
domain
Fibronectin type-III 12
1787
1879
domain
Fibronectin type-III 13
1886
1979
modified residue
Phosphoserine
2071
2071
modified residue
Phosphothreonine
2074
2074
modified residue
Phosphoserine
2113
2113
modified residue
Phosphoserine
2117
2117
glycosylation site
N-linked (GlcNAc...)
potential
164
164
glycosylation site
N-linked (GlcNAc...)
potential
250
250
glycosylation site
N-linked (GlcNAc...)
potential
318
318
glycosylation site
N-linked (GlcNAc...)
potential
327
327
glycosylation site
N-linked (GlcNAc...)
potential
463
463
glycosylation site
N-linked (GlcNAc...)
potential
485
485
glycosylation site
N-linked (GlcNAc...)
potential
491
491
glycosylation site
N-linked (GlcNAc...)
potential
628
628
glycosylation site
N-linked (GlcNAc...)
potential
661
661
glycosylation site
N-linked (GlcNAc...)
potential
707
707
glycosylation site
N-linked (GlcNAc...)
potential
809
809
glycosylation site
N-linked (GlcNAc...)
870
870
glycosylation site
N-linked (GlcNAc...)
potential
942
942
glycosylation site
N-linked (GlcNAc...)
potential
1019
1019
glycosylation site
N-linked (GlcNAc...)
potential
1094
1094
glycosylation site
N-linked (GlcNAc...)
potential
1109
1109
glycosylation site
N-linked (GlcNAc...)
potential
1172
1172
glycosylation site
N-linked (GlcNAc...)
potential
1203
1203
glycosylation site
N-linked (GlcNAc...)
potential
1282
1282
glycosylation site
N-linked (GlcNAc...)
potential
1329
1329
glycosylation site
N-linked (GlcNAc...)
potential
1379
1379
glycosylation site
N-linked (GlcNAc...)
potential
1414
1414
glycosylation site
N-linked (GlcNAc...)
potential
1420
1420
glycosylation site
N-linked (GlcNAc...)
potential
1843
1843
glycosylation site
N-linked (GlcNAc...)
potential
1876
1876
splice variant
(in isoform C)
0
0
compositionally biased region
Poly-Gln
65
70
SP Length
47
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MLKSAASSLRRRRPKTTITATLAIEMPSQPKLASLLAVLVLLCYCDS
Sequence
MLKSAASSLRRRRPKTTITATLAIEMPSQPKLASLLAVLVLLCYCDS
CFF
CYADANLQQQNSIV
QQQQLQ
A
PRFTTHPSSSGSIVSEGSTKILQCHALGY
PQPTYRWLKDGVPVGDFSSSQFYRFHSTRREDAGSYQCIARNDAGSIFSE
KSDVV
VAYMGIFE
N
TTEGRLTVISGHPAIFDMPPIESIPVPSVMWQSEDG
PLNYDIKYAFTHANQLIILSADENDRKGYRAKAINTQLGKEESSAFVHL
N
VSGDPYIEVA
PEIIVRPQDVKVKVGTGVVELQCIANARPLHELETLWLKD
GLAVETAGVRHTLNDPW
N
RTLALLQA
N
SSHSGEYTCQVRLRSGGYPAVSA
SARLQ
ILE
PPLFFTPMRAETFGEFGGQVQLTCDVVGEPTPQVKWFRNAES
VDAHIESGRYTLNTDNTLVIKKLILDDAAMFQCLAINEAGENSAS
TWLRV
KTSA
PIMELPPQ
N
VTALDGKDATISCRAVGSPNP
N
ITWIY
N
ETQLVDISS
RVQILESGDLLISNIRSVDAGLYICVRANEAGSVKGEAYLS
VLVR
TQIIQ
PPVDTTVLLGLTATLQCKVSSDPSVPYNIDWYREGQSSTPISNSQRIGVQ
ADGQLEIQAVRASDVGSYACVVTSPGG
N
ETRAARLS
VIEL
PFPPSNVKVE
RLPEPQQRSI
N
VSWTPGFDGNSPISKFIIQRREVSELEKFVGPVPDPLLN
WITELS
N
VSADQRWILLENLKAATVYQFRVSAVNRVGEGSPSEPSNVV
EL
PQEA
PSGPPVGFVGSARSMSEIITQWQPPLEEHRNGQILGYILRYRLFGY
NNVPWSYQ
N
ITNEAQRNFLIQELITWKDYIVQIAAYNNMGVGVYTEGSKI
KT
KEGV
PEAPPTNVKVEAI
N
STAARCRWTPPNPQQINGINQGYKIQAWQR
RLIDGEWRDIERRMKTVPPSLIDPLAEQTAILGGLEKFTEY
N
ISVLCFTD
PGDGVASSQVAVMT
MDDV
PDEVTGLHFDDVSDRSVKVLWAPPRASNGILT
GYTVRYQVKDRPDTLKSF
N
LTADDTELTVNQLQATTHYWFEIVAWTRVGS
GIPKTATIQS
GVEPVL
PHAPTALALSNIEAFSVVLQFTPGFDG
N
SSITKW
KVEGQTAR
N
MTWFTICEINDPDAETLTVTGLVPFTQYRLRLSASNVVGSS
KPSEATKDF
QTIQAR
PKHPPF
N
VTVRAMSAQQLRVRWIPLQQTEWYGNPR
GY
N
ISYKQLVKTPGTIKYVPRSVVIEDHTANSHVLDSLEEWTLYEVKMNA
CNDVGCSKESDTAVERT
REAV
PSYGPLDVQA
N
ATSSTTVVVQWGEVPRQH
RNGQIDGYKVFYAAADRGQQVLHKTIPN
N
ATFTTTLTELKKYVVYHVQVL
AYTRLGNGALSTPPIRV
QTFEDT
PGVPS
N
VSFPDVSLTMARIIWDVPVDP
NGKILAYQVTYTL
N
GSAML
N
YSREFPPSDRTFRATELLPGKYYSFSCTAQ
TRLGWGKIATALVYT
TNNRER
PQAPSVPQISRSQIQAHQITFSWTPGRDG
FAPLRYYTVEMRENEGRWQPLPERVDPSLSSFTAVGLRPYMTYQFRIQAT
NDLGPSAFSRESVIVRT
LPAA
PAVGVGGLKVVPITTTSVRVQWSALETAL
WNGDASTGGYRILYQQLSDFPTALQSTPKTDVHGINENSVVLSDLQQDRN
YEIVVLPFNSQGPGPATPPAAV
YVGEAV
PTGEPRAVDAAPISSTEVRLLW
KPPKQSMQNGDILGYKIYYLVTYSPQALEPGRKWEEEIEVVSATATSHSL
VFLDKFTEYRIQLLAFNPAGDGPRSAPITVKT
LPGV
PSAPLHLRFSDITM
QSLEVTWDPPKFLNGEILGYLVTYETTEENEKFSKQVKQKVS
N
TTLRVQN
LEEEVTYTFTVRAQTSVDYGPGISE
N
VTT
GPQDGS
PVAPRDLILTKTLSS
VEMHWINGPSGRGPILGYLIEAKKRDDSRWTKIEQTRKGMMQDFTVSYHI
LMPSTAYTFRVIAYNRYGISFPVYSKDSI
LTPSKLHLEYGYLQHKPFYRQ
T
WFMVSLAATSIVIIVMVIAVL
CVKSKSYKYKQEAQKTLEESMAMSIDER
QELALELYRSRHGVGTGTLN
S
VG
T
LRSGTLGTLGRKSTSRPPPGVHLGKS
PPRPSPASVAYH
S
DEE
S
LKCYDENPDDSSVTEKPSEVSSSEASQHSESEN
ESVRSDPHSFVNHYANVNDSLRQSWKKTKPVRNYSSYTDSEPEGSAVMSL
NGGQIIVNNMARSRAPLPGFSSFV
Original
MLKSAASSLRRRRPKTTITATLAIEMPSQPKLASLLAVLVLLCYCDSCFF
CYADANLQQQNSIVQQQQLQAPRFTTHPSSSGSIVSEGSTKILQCHALGY
PQPTYRWLKDGVPVGDFSSSQFYRFHSTRREDAGSYQCIARNDAGSIFSE
KSDVVVAYMGIFENTTEGRLTVISGHPAIFDMPPIESIPVPSVMWQSEDG
PLNYDIKYAFTHANQLIILSADENDRKGYRAKAINTQLGKEESSAFVHLN
VSGDPYIEVAPEIIVRPQDVKVKVGTGVVELQCIANARPLHELETLWLKD
GLAVETAGVRHTLNDPWNRTLALLQANSSHSGEYTCQVRLRSGGYPAVSA
SARLQILEPPLFFTPMRAETFGEFGGQVQLTCDVVGEPTPQVKWFRNAES
VDAHIESGRYTLNTDNTLVIKKLILDDAAMFQCLAINEAGENSASTWLRV
KTSAPIMELPPQNVTALDGKDATISCRAVGSPNPNITWIYNETQLVDISS
RVQILESGDLLISNIRSVDAGLYICVRANEAGSVKGEAYLSVLVRTQIIQ
PPVDTTVLLGLTATLQCKVSSDPSVPYNIDWYREGQSSTPISNSQRIGVQ
ADGQLEIQAVRASDVGSYACVVTSPGGNETRAARLSVIELPFPPSNVKVE
RLPEPQQRSINVSWTPGFDGNSPISKFIIQRREVSELEKFVGPVPDPLLN
WITELSNVSADQRWILLENLKAATVYQFRVSAVNRVGEGSPSEPSNVVEL
PQEAPSGPPVGFVGSARSMSEIITQWQPPLEEHRNGQILGYILRYRLFGY
NNVPWSYQNITNEAQRNFLIQELITWKDYIVQIAAYNNMGVGVYTEGSKI
KTKEGVPEAPPTNVKVEAINSTAARCRWTPPNPQQINGINQGYKIQAWQR
RLIDGEWRDIERRMKTVPPSLIDPLAEQTAILGGLEKFTEYNISVLCFTD
PGDGVASSQVAVMTMDDVPDEVTGLHFDDVSDRSVKVLWAPPRASNGILT
GYTVRYQVKDRPDTLKSFNLTADDTELTVNQLQATTHYWFEIVAWTRVGS
GIPKTATIQSGVEPVLPHAPTALALSNIEAFSVVLQFTPGFDGNSSITKW
KVEGQTARNMTWFTICEINDPDAETLTVTGLVPFTQYRLRLSASNVVGSS
KPSEATKDFQTIQARPKHPPFNVTVRAMSAQQLRVRWIPLQQTEWYGNPR
GYNISYKQLVKTPGTIKYVPRSVVIEDHTANSHVLDSLEEWTLYEVKMNA
CNDVGCSKESDTAVERTREAVPSYGPLDVQANATSSTTVVVQWGEVPRQH
RNGQIDGYKVFYAAADRGQQVLHKTIPNNATFTTTLTELKKYVVYHVQVL
AYTRLGNGALSTPPIRVQTFEDTPGVPSNVSFPDVSLTMARIIWDVPVDP
NGKILAYQVTYTLNGSAMLNYSREFPPSDRTFRATELLPGKYYSFSCTAQ
TRLGWGKIATALVYTTNNRERPQAPSVPQISRSQIQAHQITFSWTPGRDG
FAPLRYYTVEMRENEGRWQPLPERVDPSLSSFTAVGLRPYMTYQFRIQAT
NDLGPSAFSRESVIVRTLPAAPAVGVGGLKVVPITTTSVRVQWSALETAL
WNGDASTGGYRILYQQLSDFPTALQSTPKTDVHGINENSVVLSDLQQDRN
YEIVVLPFNSQGPGPATPPAAVYVGEAVPTGEPRAVDAAPISSTEVRLLW
KPPKQSMQNGDILGYKIYYLVTYSPQALEPGRKWEEEIEVVSATATSHSL
VFLDKFTEYRIQLLAFNPAGDGPRSAPITVKTLPGVPSAPLHLRFSDITM
QSLEVTWDPPKFLNGEILGYLVTYETTEENEKFSKQVKQKVSNTTLRVQN
LEEEVTYTFTVRAQTSVDYGPGISENVTTGPQDGSPVAPRDLILTKTLSS
VEMHWINGPSGRGPILGYLIEAKKRDDSRWTKIEQTRKGMMQDFTVSYHI
LMPSTAYTFRVIAYNRYGISFPVYSKDSILTPSKLHLEYGYLQHKPFYRQ
TWFMVSLAATSIVIIVMVIAVLCVKSKSYKYKQEAQKTLEESMAMSIDER
QELALELYRSRHGVGTGTLNSVGTLRSGTLGTLGRKSTSRPPPGVHLGKS
PPRPSPASVAYHSDEESLKCYDENPDDSSVTEKPSEVSSSEASQHSESEN
ESVRSDPHSFVNHYANVNDSLRQSWKKTKPVRNYSSYTDSEPEGSAVMSL
NGGQIIVNNMARSRAPLPGFSSFV
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11